Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reporting the safety and efficacy of obatoclax mesylate in combination with docetaxel for non-small cell lung cancer; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Obatoclax mesylate (GX15-070MS) (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED